10+ years of experience in understanding functional screens and drug drug interaction 

 

rene Bernards

Professor Molecular Carcinogenesis at the Netherlands Cancer Institute, Founder Topotarget, Agendia

Bas van der baan

Chief Clincal and Business Development Agendia, co-founder thromboDx

Roderick beijersbergen

Division head screening facility Netherlands Cancer Institute